PERSPECTA

News from every angle

← Back to headlines

RBC Capital Lifts Price Target for Incyte Corporation

RBC Capital has raised its price target for Incyte Corporation (INCY) from $92 to $95. This upward adjustment reflects a more positive financial outlook for the biopharmaceutical company.

20 Apr, 00:08 — 20 Apr, 00:08
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual7d ago

RBC Capital Lifts PT on Incyte Corporation (INCY) to $95 From $92

Read full article →

Related Stories

Police discover unlicensed daycare with over 20 toddlers in Jerusalem

just now

Dietitian Explains Why Healthy Foods Can Cause Bloating

17m ago

62-Year-Old Collapses After Morning Walk Due to Heat Wave Stress

19m ago

Pakistan Government Fixes Prices of 35 Essential Drugs to Combat Shortages

20m ago